Although PYK2 was identified as a potential therapeutic target, more studies are needed to fully elucidate the mechanisms by which PYK2 promotes endometriosis and to validate the efficacy and safety of targeting PYK2 in a clinical setting. This evidence concerns the gene PTK2B and endometriosis.